| Dr.Miasma vs King | 16–15 | 51.61% |
| Dr.Miasma vs Jin | 14–15 | 48.28% |
| Dr.Miasma vs Anna | 11–15 | 42.31% |
| Dr.Miasma vs Bryan | 8–17 | 32.00% |
| Dr.Miasma vs Kazuya | 10–15 | 40.00% |
| Dr.Miasma vs Steve | 12–12 | 50.00% |
| Dr.Miasma vs Law | 10–13 | 43.48% |
| Dr.Miasma vs Armor King | 13–8 | 61.90% |
| Dr.Miasma vs Yoshimitsu | 7–11 | 38.89% |
| Dr.Miasma vs Reina | 11–7 | 61.11% |
| Dr.Miasma vs Heihachi | 8–10 | 44.44% |
| Dr.Miasma vs Alisa | 4–10 | 28.57% |
| Dr.Miasma vs Nina | 3–11 | 21.43% |
| Dr.Miasma vs Asuka | 9–4 | 69.23% |
| Dr.Miasma vs Dragunov | 2–7 | 22.22% |
| Dr.Miasma vs Victor | 7–1 | 87.50% |
| Dr.Miasma vs Fahkumram | 3–5 | 37.50% |
| Dr.Miasma vs Devil Jin | 6–1 | 85.71% |
| Dr.Miasma vs Clive | 2–5 | 28.57% |
| Dr.Miasma vs Jack-8 | 2–4 | 33.33% |
| Dr.Miasma vs Jun | 3–3 | 50.00% |
| Dr.Miasma vs Feng | 1–4 | 20.00% |
| Dr.Miasma vs Leroy | 3–2 | 60.00% |
| Dr.Miasma vs Azucena | 5–0 | 100.00% |
| Dr.Miasma vs Miary Zo | 1–4 | 20.00% |
| Dr.Miasma vs Leo | 0–4 | 0.00% |
| Dr.Miasma vs Lee | 2–2 | 50.00% |
| Dr.Miasma vs Eddy | 2–2 | 50.00% |
| Dr.Miasma vs Xiaoyu | 1–2 | 33.33% |
| Dr.Miasma vs Lili | 0–3 | 0.00% |
| Dr.Miasma vs Lars | 1–2 | 33.33% |
| Dr.Miasma vs Raven | 0–3 | 0.00% |
| Dr.Miasma vs Hwoarang | 0–2 | 0.00% |
| Dr.Miasma vs Kuma | 0–2 | 0.00% |
| Dr.Miasma vs Lidia | 1–1 | 50.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.